Published in Health Res Policy Syst on December 03, 2016
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03
The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ (1999) 2.46
Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan (2006) 1.94
The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy (2000) 1.86
A systematic review of the use of economic evaluation in local decision-making. Health Policy (2008) 1.29
Innovation for universal health coverage in Bangladesh: a call to action. Lancet (2013) 1.25
Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care (2005) 1.25
The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy (1997) 1.10
A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006. Med Decis Making (2010) 1.08
Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health (2010) 1.06
The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology. Int J Technol Assess Health Care (2000) 1.04
A systematic review of coverage decision-making on health technologies-evidence from the real world. Health Policy (2012) 0.99
A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One (2014) 0.94
Adjusting life for quality or disability: stylistic difference or substantial dispute? Health Econ (2009) 0.93
Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. Eur J Health Econ (2004) 0.93
Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature. Health Econ (2016) 0.92
Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy (2015) 0.83
Making health technology assessment information available for decision making: the development of a Thai database. J Med Assoc Thai (2008) 0.81
The European Network of Health Economic Evaluation Databases (EURO NHEED) Project. Eur J Health Econ (2004) 0.80
Reflections on the development of health economics in low- and middle-income countries. Proc Biol Sci (2014) 0.79
The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand. Value Health (2010) 0.77
Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis. PLoS One (2015) 0.79
Cost-utility analysis of dasatinib and nilotinib in patients with chronic myeloid leukemia refractory to first-line treatment with imatinib in Thailand. Clin Ther (2014) 0.78